Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Studying the Conductivity of Polystyrene Using 2-(Sub.)-5- [3-(5-Nitro-Fur-2-Yl)-Propen-2-Yldiene]amino 1,3,4- Thidiazoles as Additives by Measuring Forbidden Energy Gap
Journal of Al-Nahrain University Science
The Active Site in -Chymotrypsin: Methyl 3,4-Dihydroisocoumarin-3-Carboxylate I
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Análise Conformacional Das 2-Feniltio, 2-Fenilsulfinil E 2-Fenilsulfonil-N,n-Dietilacetamidas E 2-Feniltio, 2-Fenilsulfinil E 2-Fenilsulfonil-Cicloexanonas 4'-Substituídas
Complete Genome Sequence of Clostridium Butyricum Strain DKU_butyricum 4-1, Isolated From Infant Feces
Microbiology Resource Announcements
Immunology
Genetics
Molecular Biology
Microbiology
Figure 1 From: Ito Y, Tanaka N (2014) Chromosome Studies in the Aquatic Monocots of Myanmar: A Brief Review With Additional Records. Biodiversity Data Journal 2: E1069.
X-Ray Crystal Structure of N'-[(1e)-1-(2,4-Dihydroxyphenyl)-Ethylidene]pyridine-4-Carbohydrazide
JOURNAL OF PHARMACEUTICAL CHEMISTRY
Discovery of Radio Emission From the Symbiotic X-Ray Binary System GX 1+4
Monthly Notices of the Royal Astronomical Society: Letters
Astrophysics
Astronomy
Planetary Science
Space
Inhibition of the 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Pathway Induces P53-Independent Transcriptional Regulation of P21WAF1/CIP1in Human Prostate Carcinoma Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Efficacy and Safety of 1:1 Fixed Ratio Combination of Insulin Glargine/Lixisenatide (iGlarLixi) Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial
Efficacy and Safety of 1:1 Fixed Ratio Combination of Insulin Glargine/Lixisenatide (iGlarLixi) Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial
‹
922
923
924
925
926
927
928
›